Purchases and Sales Made in Q1 2023 in Cytom X Therapeutics, Inc. (CTMX)
This table provides information about the institutional ownership of Cytom X Therapeutics, Inc. (CTMX) during Q1 2023. The information is specifically focused on institutions that hold shares of CytomX Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 12, 2023
Q1 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-176K- 13.56% |
$261K - $508K
|
1.12M
$2.6M
|
|
May 15, 2023
Q1 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-179K- 39.14% |
$265K - $516K
|
279K
$644K
|
|
Apr 18, 2023
Q1 2023
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-247K- 26.98% |
$365K - $711K
|
668K
$1.54M
|
|
May 15, 2023
Q1 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-273K- 36.87% |
$404K - $787K
|
468K
$1.08M
|
|
May 15, 2023
Q1 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-318K- 51.35% |
$470K - $914K
|
301K
$695K
|
|
May 12, 2023
Q1 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-490K- 36.58% |
$726K - $1.41M
|
850K
$1.96M
|
|
May 15, 2023
Q1 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-759K- 44.12% |
$1.12M - $2.19M
|
961K
$2.22M
|